Literature DB >> 35165443

M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.

Sahana D Rao1, Qifeng Chen2, Qinghui Wang2, Elizabeth L Orth-He1, Michelle Saoi3, Andrew R Griswold4,5, Abir Bhattacharjee2, Daniel P Ball2, Hsin-Che Huang1, Ashley J Chui1, Dominic J Covelli2, Shaochen You2, Justin R Cross3, Daniel A Bachovchin6,7,8,9.   

Abstract

Inflammasomes are multiprotein complexes that sense intracellular danger signals and induce pyroptosis. CARD8 and NLRP1 are related inflammasomes that are repressed by the enzymatic activities and protein structures of the dipeptidyl peptidases 8 and 9 (DPP8/9). Potent DPP8/9 inhibitors such as Val-boroPro (VbP) activate both NLRP1 and CARD8, but chemical probes that selectively activate only one have not been identified. Here we report a small molecule called CQ31 that selectively activates CARD8. CQ31 inhibits the M24B aminopeptidases prolidase (PEPD) and Xaa-Pro aminopeptidase 1 (XPNPEP1), leading to the accumulation of proline-containing peptides that inhibit DPP8/9 and thereby activate CARD8. NLRP1 is distinct from CARD8 in that it directly contacts DPP8/9's active site; these proline-containing peptides, unlike VbP, do not disrupt this repressive interaction and thus do not activate NLRP1. We expect that CQ31 will now become a valuable tool to study CARD8 biology.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35165443      PMCID: PMC9179932          DOI: 10.1038/s41589-021-00964-7

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   16.174


  49 in total

1.  Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity.

Authors:  Joshua N Finger; John D Lich; Lauren C Dare; Michael N Cook; Kristin K Brown; Chaya Duraiswami; John Bertin; John J Bertin; Peter J Gough
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

Review 2.  Mechanisms and functions of inflammasomes.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

Review 3.  Inflammasome Complexes: Emerging Mechanisms and Effector Functions.

Authors:  Vijay A K Rathinam; Katherine A Fitzgerald
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

Review 4.  Inflammasomes: mechanism of assembly, regulation and signalling.

Authors:  Petr Broz; Vishva M Dixit
Journal:  Nat Rev Immunol       Date:  2016-06-13       Impact factor: 53.106

5.  N-terminal degradation activates the NLRP1B inflammasome.

Authors:  Ashley J Chui; Marian C Okondo; Sahana D Rao; Kuo Gai; Andrew R Griswold; Darren C Johnson; Daniel P Ball; Cornelius Y Taabazuing; Elizabeth L Orth; Brooke A Vittimberga; Daniel A Bachovchin
Journal:  Science       Date:  2019-03-14       Impact factor: 47.728

6.  Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes.

Authors:  Andrew Sandstrom; Patrick S Mitchell; Lisa Goers; Edward W Mu; Cammie F Lesser; Russell E Vance
Journal:  Science       Date:  2019-03-14       Impact factor: 47.728

7.  NLRP1: a jack of all trades, or a master of one?

Authors:  Daniel A Bachovchin
Journal:  Mol Cell       Date:  2021-02-04       Impact factor: 17.970

8.  CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain.

Authors:  Andrea D'Osualdo; Christian X Weichenberger; Roland N Wagner; Adam Godzik; John Wooley; John C Reed
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

9.  Proteolytic processing of Nlrp1b is required for inflammasome activity.

Authors:  Bradley C Frew; Vineet R Joag; Jeremy Mogridge
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

Review 10.  The NLRP1 and CARD8 inflammasomes.

Authors:  Cornelius Y Taabazuing; Andrew R Griswold; Daniel A Bachovchin
Journal:  Immunol Rev       Date:  2020-06-19       Impact factor: 12.988

View more
  2 in total

Review 1.  Inflammasome activation: from molecular mechanisms to autoinflammation.

Authors:  Samuel Lara-Reyna; Emily A Caseley; Joanne Topping; François Rodrigues; Jorge Jimenez Macias; Sean E Lawler; Michael F McDermott
Journal:  Clin Transl Immunology       Date:  2022-07-07

Review 2.  How Pyroptosis Contributes to Inflammation and Fibroblast-Macrophage Cross-Talk in Rheumatoid Arthritis.

Authors:  Benjamin Demarco; Sara Danielli; Fabian A Fischer; Jelena S Bezbradica
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.